Impact of meningococcal group B OMV vaccines, beyond their brief

Predicted vs observed effectiveness of outer membrane vesicle (OMV) vaccines against meningococcal serogroup B disease: Systematic review

(2017) Thomas Harder et al.   JOURNAL OF INFECTION

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

(2017) Helen Petousis-Harris et al.   LANCET

Gonorrhoea vaccines: a step in the right direction

(2017) Kate L Seib   LANCET

Sexually transmitted infections: challenges ahead

(2017) Magnus Unemo et al.   LANCET INFECTIOUS DISEASES

Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action

(2017) Teodora Wi et al.   PLOS MEDICINE

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

(2016) Sydel R Parikh et al.   LANCET

Immunogenicity of a Meningococcal B Vaccine during a University Outbreak

(2016) Nicole E. Basta et al.   NEW ENGLAND JOURNAL OF MEDICINE

The potential impact of vaccination on the prevalence of gonorrhea

(2015) Andrew P. Craig et al.   VACCINE

Review of meningococcal vaccines with updates on immunization in adults

(2014) Yorgo C Zahlanie et al.   Human Vaccines & Immunotherapeutics

Potential impact of vaccination against Neisseria meningitidis on Neisseria gonorrhoeae in the United States: Results from a decision-analysis model

(2014) Stéphane A Régnier et al.   Human Vaccines & Immunotherapeutics

Phase Variation of PorA, a Major Outer Membrane Protein, Mediates Escape of Bactericidal Antibodies by Neisseria meningitidis

(2013) Isfahan Tauseef et al.   INFECTION AND IMMUNITY

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future

(2013) Johan Holst et al.   Human Vaccines & Immunotherapeutics

Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae

(2012) Ronza Hadad et al.   APMIS

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak

(2011) François Caron et al.   LANCET INFECTIOUS DISEASES

Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand

(2011) Richard Arnold et al.   VACCINE

Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age

(2010) Matthew D. Snape et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease

(2009) Dan M. Granoff   VACCINE

Mucosal Immunity in Healthy Adults after Parenteral Vaccination with Outer‐Membrane Vesicles fromNeisseria meningitidisSerogroup B

(2008) Victoria Davenport et al.   JOURNAL OF INFECTIOUS DISEASES

MeNZB™ vaccine and epidemic control: When do you stop vaccinating?

(2008) Belinda J. Loring et al.   VACCINE